Skip to content
RDY150

Drawing based on the label description. No photo yet.

“150 mg white to pale yellow colored granular powder filled in capsule shell with red opaque colored cap and body imprinted with RDY on cap and 150 on body in black ink”

RDY 150 pill

Pill with imprint RDY 150 is red, capsule, 19 mm and has been identified as Nilotinib 150 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Dr. Reddy's Laboratories Inc.

Nilotinib 150 mg

Imprint
RDY 150
Strength
150 mg
Used for
Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
Color
Red
Shape
Capsule / oblong
Size
19 mm
Score
No score line
Form
Capsule
Manufacturer
Dr. Reddy's Laboratories Inc
Drug class
Cancer medicine (kinase inhibitor)
NDC
43598-455, 43598-455-74, 43598-455-46

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Nilotinib pills and guides

What is Nilotinib used for?

Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Adult Patients With Newly Diagnosed Ph+ CML-CP

Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP

Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows RDY 150. The parts can be split between the two sides, so turn the pill over and check both.
  • It is red, capsule, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Nilotinib Hydrochloride Monohydrate

Inactive: Silicon Dioxide, Crospovidone, Lactose Monohydrate, Magnesium Stearate, Poloxamer 188, Gelatin, Ferric Oxide Red, Ferric Oxide Yellow, Sodium Lauryl Sulfate, Titanium Dioxide, Ferrosoferric Oxide, Potassium Hydroxide, Propylene Glycol, Shellac, Ammonia

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Nilotinib pills